PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 24, 2026Inflammatory Bowel Diseases0 citations

Cohousing of Non-Inflamed MDR Mice With Ileocolitic MDR Mice Alters Their Colonic Microbiota and Attenuates Ileitis in Ileocolitic Mice, Without Inducing Either Phenotype in Non-Inflamed Counterparts

View Full Paper
ARAchyuta RameshACAmruth ChilukuriZSZining Shen

Key Points

  • This research aims to understand how cohousing affects the severity of ileitis in MDR1a-/- mice and their colonic microbiota.
  • Analyzed histopathology of ileal and colonic tissues at multiple time points
  • Examined mesenteric lymph nodes using mass cytometry
  • Cohoused ileocolitic mice with non-colitic mice and evaluated their health
  • Conducted metagenomic analyses before and after cohousing
  • Ileitis developed between 5 and 12 weeks; severity stable afterward
  • Colitis first observed at 12 weeks and worsened by 30 weeks
  • Cohousing attenuated ileitis in ileocolitic mice without inducing disease in non-colitic mice
  • Changes in microbial communities included increased diversity in ileocolitic mice and decreased specific bacteria in Taconic mice

Abstract

Abstract Background/Aims Crohn’s disease involvement may be restricted to the terminal ileum (ileitis), colon (colitis) or both (ileocolitis). Mutations in the NOD2 gene, and development of antibacterial antibodies are more prevalent in ileal CD suggesting that ileitis may represent a distinct disease entity. The determinants of this regional distribution are not known but are likely bacterial in origin. MDR1a-/- housed at our facility develop not only colitis but also ileitis. However, the colony from which they are derived at Taconic does not develop ileitis or colitis. Here, we characterize the time course of ileocolitis in MDR1a-/- mice at UCSD and examine the effect of cohousing with non-colitic MDR1α−/− mice from Taconic on ileocolitis severity and ileal and colonic microbial communities. METHODS The severity of ileal and colonic histopathological involvement was analyzed at 5, 12, 20, and 30 weeks old by a pathologist in a blinded fashion. Relevant cellular subsets of mesenteric lymph nodes (MLN) in inflamed and non-inflamed mice were examined via mass cytometry. Mice originating from colonies with and without colitis were cohoused, after which their ilea and colon were harvested for histopathologic evaluation. Metagenomic analyses (shotgun) were performed in ileum contents and stool before and after cohousing. RESULTS Mice develop ileitis between 5 and 12 weeks (n 7 for all time points, p 0.01), and its severity remains relatively stable afterwards. Colitis was first observed at 12-weeks-of age, remained stable through 20 weeks and worsened in 30-week-old mice (p 0.01). Cellular composition of MLN showed expansion of central memory (TCM (CD44+/CD62L+) CD8+ T cells) in inflamed mice from our colony compared with non-colitic mice from Taconic (n = 4, p 0.005). Cohousing experiments showed attenuation of ileitis in ileocolitic mice (UCSD colony, n = 4, p 0.05), when co-housed with non-colitic mice from the Taconic colony, which were not affected. Cohousing did not trigger ileitis or colitis in mice from Taconic. After cohousing, Taconic mice had a loss of verrucomicrobiales and increased campylobacterales, whereas in UCSD mice, desulfovibrionales increased along with overall diversity and lactobacillales decreased. Evaluation of the ileal microbiota is ongoing. CONCLUSIONS MDR1α -/- mice at our vivarium develop not only colitis but also ileitis (ileocolitis) between 5 and 12 weeks-of age with expansion of TCM in their MLN. Cohousing of ileocolitic mice (UCSD) with non-inflamed mice from Taconic carrying an identical MDR1α mutation led to attenuation of ileitis but not colitis. Thus, mice at Taconic appear to have transmissible beneficial (anti-inflammatory) elements in their microbiota able to attenuate ileitis in their ileocolitic MDR1α -/- counterparts at our facility.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ramesh et al. (2026) studied this question.

synapsesocial.com/papers/6974610cbb9d90c67120ae52https://doi.org/10.1093/ibd/izag006.116
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Microbiota-dependent model of immune checkpoint inhibitor colitis characterized by inflammatory immune cells and altered hematopoiesis 90882025
  2. 2A1 PRE-CLINICAL CROHN’S DISEASE MICROBIOME PROMOTES INFLAMMATION IN GNOTOBIOTIC RECIPIENT MICE2024 · 1 citations
  3. 3ISM012-042 (ISM5411), A PHD1/2 INHIBITOR, PREVENTATIVELY AND THERAPEUTICALLY MITIGATES T CELL TRANSFER-INDUCED COLITIS IN MICE2026 · 1 citations
  4. 4Gut Microbial Impact on Colitis and Colitis-Associated Carcinogenesis in a Primary Sclerosing Cholangitis-IBD Model2024
  5. 5Supplementary Figure S2 from Neutrophils Mediate Protection Against Colitis and Carcinogenesis by Controlling Bacterial Invasion and IL22 Production by γδ T Cells2024